ALGS

Aligos Therapeutics, Inc.

• Dow Jones·03/26 14:25

  Aligos Therapeutics Price Target Announced at $48.00/Share by WestPark Capital

• Benzinga·03/26 14:15

  WestPark Capital Initiates Coverage On Aligos Therapeutics with Buy Rating, Announces Price Target of $48

• TipRanks·03/26 13:00

  Aligos Therapeutics initiated with a Buy at WestPark Capital

• Dow Jones·03/19 19:50

  Aligos Therapeutics Price Target Cut to $48.00/Share From $60.00 by Jefferies

• Benzinga·03/19 19:40

  Jefferies Assumes Aligos Therapeutics at Buy, Lowers Price Target of $48

• TipRanks·03/19 09:15

  Aligos Therapeutics assumed with a Buy at Jefferies

• Dow Jones·03/11 17:28

  Aligos Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

• Benzinga·03/11 17:19

  HC Wainwright & Co. Reiterates Buy on Aligos Therapeutics, Maintains $50 Price Target

• TipRanks·03/11 16:40

  Analysts Are Bullish on These Healthcare Stocks: Aligos Therapeutics (ALGS), Demant (WILLF)

• TipRanks·03/09 15:50

  Analysts Offer Insights on Healthcare Companies: Aligos Therapeutics (ALGS) and Cresco Labs (OtherCRLBF)

• NASDAQ·03/06 01:01

  Aligos Reports FY25 Results, Highlights Progress Across Liver And Viral Disease Pipeline

• Seeking Alpha·03/05 18:02

  Aligos Therapeutics GAAP EPS of -$1.91 beats by $0.12

• TipRanks·03/05 13:14

  Aligos Therapeutics reports Q4 EPS ($1.91), consensus ($2.49)

• Benzinga·03/05 13:14

  Aligos Therapeutics Earnings Report: Q4 Overview

• Reuters·03/05 13:10

  Aligos Therapeutics Q4 net loss narrows